The Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403. doi:10.1056/NEJMoa012512
2.
Diabetes Prevention Program Research Group,KnowlerWCFowlerSE, et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374(9702):1677-1686. doi:10.1016/S0140-6736(09)61457-4. Erratum in: Lancet. 2009;374(9707):2054.
3.
Diabetes Prevention Program Research Group. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study. Lancet Diabetes Endocrinol. 2015;3(11):866-875. doi:10.1016/S2213-8587(15)00291-0
DiBenedettoJCBlumNMO’BrianCAKolbLELipmanRD. Achievement of weight loss and other requirements of the Diabetes Prevention and Recognition Program: a national diabetes prevention program network based on nationally certified diabetes self-management education programs. Diabetes Educ. 2016;42(6):678-685. doi:10.1177/0145721716668415
6.
PerreaultLKahnSEChristophiCAKnowlerWCHammanRF; Diabetes Prevention Program Research Group. Regression from pre-diabetes to normal glucose regulation in the diabetes prevention program. Diabetes Care. 2009;32(9):1583-1588. doi:10.2337/dc09-0523
7.
PerreaultLPanQMatherKJWatsonKEHammanRFKahnSE. Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study. Lancet. 2012;379(9833):2243-2251. doi:10.1016/S0140-6736(12)60525-X
8.
ElSayedNAAleppoGArodaVR, et al. American Diabetes Association. 8. Obesity and weight management for the prevention and treatment of type 2 diabetes: Standards of Care in Diabetes—2023. Diabetes Care. 2023;46(suppl 1):S128-S139. doi:10.2337/dc23-S008
